Bioventus Inc. (BVS)
Nasdaq: BVS · Surgical & Medical Instruments & Apparatus · Durham, NC · filing with the SEC since 2016
Grade5.2
◀ Past 5.0● Present 5.9▶ Future 4.4
Filings
188 filings since 2017 beside 265 insider forms · Accelerated filer and emerging growth company · read from EDGAR on Nov 13, 2026Due nextAccelerated filer and emerging growth company
10-K
Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends.
by Mar 16, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 37 days after the quarter ended. The proxy statement was last filed Apr 22, 2026.
Filings a yearinsider forms included
107987376975844
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Nov 17, 2025.SEC letters: 2 in the last 36 months, the newest Nov 1, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Aug 4, 2025
8-K items 1.01, 2.03, 9.01
Major agreement signed; New debt or obligation taken on · Current report
Jul 31, 2025
Jan 3, 2025
8-K items 2.01, 8.01, 9.01
Purchase or sale of a business completed; Other event · Current report
Dec 31, 2024
40 of 188 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.